Secondary metastases resection after bevacizumab plus irinotecan-based chemotherapy in first-line therapy of metastatic colorectal cancer in a real-life setting: results of the ETNA cohort

Nom du journal : Target Oncol

Année : 2016

Volume : 11

Page de départ : 83

Page de fin : 92

Auteurs: Rouyer M, Smith D, Laurent C, Bécouarn Y, Guimbaud R, Michel P, Tubiana-Mathieu N, Balestra A, Jové J, Robinson P, Noize P, Moore N, Ravaud A, Fourrier-Réglat A, on behalf of the ETNA study group, Robinson P,